Genetic testing for critically ill newborns in northeast China
Part of Digestive system clinical trials.
This study uses advanced DNA and RNA testing to find genetic causes of serious illness in newborns. It aims to give families a faster, more accurate diagnosis and better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The baby is under 3 months old
- The baby is critically ill, and doctors suspect a genetic cause based on symptoms or family history
- Parents or guardians agree to the study and allow rapid whole-genome sequencing of the baby's DNA
- If the DNA test is negative, an additional RNA test (transcriptome sequencing) will be done
- The illness is not caused by pregnancy, infection, lack of oxygen, or other non-genetic factors
- The baby does not already have a genetic diagnosis that fully explains the illness
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers genetic testing for infants under 18 months who are in intensive care with certain health problems that may be genetic. The goal is to find a genetic cause quickly, which could guide care and treatment.
This study collects genetic information from very young newborns to better understand early-life health. Your child’s information may help researchers learn about genetics and future research.
This study uses whole-genome sequencing (a DNA test that looks across the genome) for newborns in the intensive care unit when doctors suspect a genetic condition. It aims to help identify possible genetic causes of illness and improve understanding for families and clinicians.
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
This study quickly reads a child’s DNA using whole genome sequencing to look for genetic causes of symptoms. It may help families and doctors better understand an underlying genetic condition and guide medical care.
Hear when a new Necrotizing Enterocolitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.